Skip to main content
Wolfson Institute of Population Health

Dr Florian Tomini


Lecturer in Health Economics

Telephone: 020 7882 6130
Room Number: 1.15


Florian holds a PhD in Economics and Public Policy Analysis from Maastricht University (NL). He also holds an MSc in Social Protection Financing from Faculty of Economics and Business, Maastricht University (NL) and an MSc in Economics and Management from Faculty of Economics, University of Tirana (Albania). Prior to joining Queen Mary University of London, Florian has held various research and academic positions at University College London (UK), University of Amsterdam (NL) and Maastricht University (NL). Florian has continuously provided his expertise on health and economic matters to national and international organisations such as NICE (UK), WHO and The World Bank.


BSc Global Health: Introduction to Health Economics


Research Interests:

Florian’s current research interests include: health economic evaluations and health technology assessment, health and social policy analysis, health micro-econometric analysis and health care financing.


Research Groups: 

Centre for Primary Care and Public Health, QMUL
Pragmatic Clinical Trials Unit, QMUL


Tomini F, Prinzen F, van Asselt ADI. A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure. Eur J Health Econ 17(9):1159-1172 Dec 2016


Tomini F, Tomini SM, Groot W. Understanding the value of social networks in life satisfaction of elderly people: a comparative study of 16 European countries using SHARE data. BMC Geriatr 16(1):203 01 Dec 2016


Tomini F, Groot W, Tomini SM. Informal care and gifts to and from older people in Europe: The interlinks between giving and receiving. BMC Health Serv Res 16(1):603 21 Oct 2016


Ramaekers BLT, Riemsma R, Tomini F, van Asselt T, Deshpande S, Duffy S, Armstrong N, Severens JL, Kleijnen J, Joore MA. Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. Pharmacoeconomics 35(2):191-202 Feb 2017


Westwood M, Ramaekers B, Whiting P, Tomini F, Joore M, Armstrong N, Ryder S, Stirk L, Severens J, Kleijnen J. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis. Health Technol Assess 19(96)

    Back to top